Medical and Pharmaceutical Industry - Market Research Report

The global animal health market is expected to reach USD 58.4 billion by 2025, according to a new study by Grand View Research, Inc. The market is driven by technological advancements in veterinary care, which are anticipated to serve future growth opportunities to the market. For instance, MediLabSecure, a laboratory network project, was initiated with an aim of identifying emerging viruses and pathogens in 19 countries in the Mediterranean regions. In addition, emergence of veterinary health information systems, specifically in the developed economies, is expected to provide high growth potential in future. With the help of these systems, data generated in veterinary clinics can be uploaded on the internet, which can be further shared with other researchers and clinicians. The incorporation of this technology will facilitate real-time analysis of fluctuations in disease prevalence. As a consequence of the aforementioned factors, it is presumed that there will be significant improv

The global carotenoids market is expected to reach USD 1.74 billion by 2025, according to a new report by Grand View Research, Inc. The growing application in human food, animal feed, dietary supplements, medicines, and cosmetic application owing to the presence of essential nutrients and vitamins in carotenoids will drive growth over the upcoming years. Furthermore, the increasing demand for these applications on account of population growth, increasing consumer surplus, and health awareness will aid in the industry expansion. The usage of these products in the pharmaceutical sector will witness substantial revenue growth at a CAGR of 4.3% from 2016 to 2025. These products act as antioxidants within the body and protect the body against chronic diseases, cellular damage, and the effects of aging. Carotenoids aid in supporting eye, skin, cardiovascular health, and are being widely used for cancer prevention. Strong growth of pharmaceutical and cosmetic industry in emerging countri

The global cardiac resynchronization therapy (CRT) market is expected to reach USD 8.8 billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of cardiac disorders and rising incidences of heart failure are expected to boost the CRT market growth over the forecast period. According to statistics published by the Sudden Cardiac Arrest Foundation, about 6.0 million people within the U.S. region suffer from cardiac disorders, of which 0.8 million are affected by atrioventricular block leading to cardiac failure. Such a huge number leads to an increased cost of about USD 20-56 billion annually. CRT devices are being predominantly used to prevent the surgical cost and readmission rate in hospitals, thereby propelling its growth. In addition, the on-going research to develop smaller, wireless/leadless and long-lasting CRT devices is expected to be a vital impact rendering driver. For instance, in September 2016, EBR Systems Inc., announced that it h

Radiant insights, inc, 'ChemoCentryx, Inc. - Product Pipeline Review - 2016', provides an overview of the ChemoCentryx, Inc.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by ChemoCentryx, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Radiant insights, inc report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Radiant insights, inc proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/uni

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Charcot-Marie-Tooth Disease Type I A - Pipeline Review, H2 2016, provides an overview of the Charcot-Marie-Tooth Disease Type I A (Genetic Disorders) pipeline landscape. Charcot-Marie-Tooth disease type 1A (CMT1A) is a type of inherited neurological disorder that affects the peripheral nerves. Symptoms include distal weakness and atrophy, sensory loss, foot deformities, and slow nerve conduction velocity. The disorder is caused by a duplication of the PMP22 gene on Chromosome 17. Symptomatic treatment includes pain medication, physical therapy and surgery. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Charcot-Marie-Tooth Disease Type I A - Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Charcot-Marie-Tooth Disease Type I A (Genetic Disorders), complete with analysis by stage of development, drug tar

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Cerebral Palsy - Pipeline Review, H1 2017, provides an overview of the Cerebral Palsy (Central Nervous System) pipeline landscape. Cerebral palsy is a group of disorders that can involve brain and nervous system functions, such as movement, learning, hearing, seeing, and thinking. Symptoms include muscles that are very tight and do not stretch, abnormal walk (gait), arms tucked in toward the sides, knees crossed or touching, legs make scissors movements, walk on the toes, speech problems (dysarthria), hearing or vision problems and pain. Treatment includes anticonvulsants and muscle relaxants. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Cerebral Palsy - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Cerebral Palsy (Central Nervous System), complete with analysis by stage of development, drug targ

The global weight management market is expected to reach USD 442.3 billion by 2025, according to a new report by Radiant insights, inc. Rising number of overweight and obese population coupled with rising popularity of various commercially available solutions is fueling the growth. Increasing initiatives undertaken by market players in collaboration with the government to raise awareness about the adverse impact on health due to obesity are further anticipated to drive the market demand. The overweight and obese population are more prone to chronic diseases including diabetes, hypertension, and orthopedic diseases. Thus, rising awareness about weight management techniques is driving the market growth. Thanks to westernization and urbanization, there is an increasing preference toward processed food as an alternative to home-cooked food. The increase in number of nuclear families coupled with a rise in the working population have fueled the demand for easily accessible & inexpe

Radiant insights, inc, 'Daiichi Sankyo Company, Limited - Product Pipeline Review - 2016', provides an overview of the Daiichi Sankyo Company, Limited's pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Daiichi Sankyo Company, Limited, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Radiant insights, inc report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Radiant insights, inc proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and f

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Drug Addiction - Pipeline Review, H1 2017, provides an overview of the Drug Addiction (Central Nervous System) pipeline landscape. Drug addiction, also called substance dependence or chemical dependency, is a disease that is characterized by a destructive pattern of drug abuse that leads to significant problems involving tolerance to or withdrawal from the substance. Drug addiction symptoms or behaviors include recurrent drug use that results in a lack of meeting important obligations at work, school, or home, inability to sleep, awake at unusual times, unusual laziness, loss of or increased in appetite, changes in eating habits, cold, sweaty palms; shaking hands., red, watery eyes; pupils larger or smaller than usual and unusual smells on breath, body or clothes. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Drug Addiction - Pipeline Review, H1 2017, p

Radiant insights, inc latest Pharmaceutical and Healthcare disease pipeline guide Degenerative Disc Disease - Pipeline Review, H1 2017, provides an overview of the Degenerative Disc Disease (Musculoskeletal Disorders) pipeline landscape. Degenerative disc disease is refers to degeneration of intervertebral discs of the spinal column. The main symptom of degenerative disc disease is pain, which often worsens during certain types of activity. Predisposing factors include aging and injury or trauma. Treatment includes non-steroidal anti-inflammatory drugs, muscle relaxants, pain relievers and antidepressants. Report Highlights Radiant insights, inc Pharmaceutical and Healthcare latest pipeline guide Degenerative Disc Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Degenerative Disc Disease (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of admi

Radiant insights, inc, 'Deep Vein Thrombosis (DVT) - Pipeline Review, H2 2016', provides an overview of the Deep Vein Thrombosis (DVT) pipeline landscape. The report provides comprehensive information on the therapeutics under development for Deep Vein Thrombosis (DVT), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Deep Vein Thrombosis (DVT) and features dormant and discontinued projects. Radiant insights, inc report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Radiant insights, inc proprietary datab

The 'Global and Chinese Tolterodine Fumarate Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Tolterodine Fumarate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tolterodine Fumarate manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2012-2017 market shares for each company. Download full research Report @ http://www.radiantinsights.com/research/global-and-chinese-tolterodine-fumarate-industry-2017 Through the statistical analysis, the report depicts t

The 'Global and Chinese Tolmetin Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Tolmetin industry with a focus on the Chinese market. The report provides key statistics on the market status of the Tolmetin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2011-2016 market shares for each company. Download full research Report @ http://www.radiantinsights.com/research/global-and-chinese-tolmetin-cas-26171-23-3-industry-2016 Through the statistical analysis, the report depicts the global and Chinese total marke

The 'Global and Chinese Ibuprofen Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Ibuprofen industry with a focus on the Chinese market. The report provides key statistics on the market status of the Ibuprofen manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2012-2017 market shares for each company. Download full research Report @ http://www.radiantinsights.com/research/global-and-chinese-ibuprofen-cas-15687-27-1-industry-2017 Through the statistical analysis, the report depicts the global and Chinese total m

The 'Global and Chinese I.V Catheter Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global I.V Catheter industry with a focus on the Chinese market. The report provides key statistics on the market status of the I.V Catheter manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. Then, the report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2011-2016 market shares for each company. Download full research Report @ http://www.radiantinsights.com/research/global-and-chinese-i-v-catheter-industry-2016 Through the statistical analysis, the report depicts the global and Chinese total mark

Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Pipeline Review, H2 2016 Summary Radiant insights, inc, 'Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) - Pipeline Review, H2 2016', provides in depth analysis on Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 or CXCR7 or ACKR3) targeted pipeline therapeutics. The report provides comprehensive information on the Atypical Chemokine Receptor 3 (C-X-C Chemokine Receptor Type 7 or Chemokine Orphan Receptor 1 or G Protein Coupled Receptor 159 or G Protein Coupled Receptor RDC1 Homolog or GPR159 o